Royal London Asset Management LTD Zoetis Inc. Transaction History

Royal London Asset Management LTD

$42.4 Billion
Q2 2025

A detailed history of Royal London Asset Management LTD transactions in Zoetis Inc. stock. As of the latest transaction made, Royal London Asset Management LTD holds 233,280 shares of ZTS stock, worth $34.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

233,280

Previous 240,521 3.01%

Holding current value

$34.2 Million

Previous $39.6 Million 8.13%

% of portfolio

0.09%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$144.41 - $170.3 $1.05 Million - $1.23 Million	-7,241 Reduced 3.01%	233,280 $36.4 Million
Q1 2025 May 13, 2025	BUY	$156.48 - $175.67 $3.91 Million - $4.39 Million	25,013 Added 11.61%	240,521 $39.6 Million
Q4 2024 Feb 11, 2025	BUY	$162.24 - $194.42 $456,705 - $547,292	2,815 Added 1.32%	215,508 $35.1 Million
Q3 2024 Nov 14, 2024	BUY	$172.58 - $196.48 $1.68 Million - $1.91 Million	9,746 Added 4.8%	212,693 $41.6 Million
Q2 2024 Aug 07, 2024	BUY	$145.54 - $178.83 $437,493 - $537,562	3,006 Added 1.5%	202,947 $35.2 Million
Q1 2024 May 14, 2024	SELL	$165.67 - $199.94 $816,587 - $985,504	-4,929 Reduced 2.41%	199,941 $33.8 Million
Q4 2023 Feb 13, 2024	BUY	$151.44 - $200.09 $909,094 - $1.2 Million	6,003 Added 3.02%	204,870 $40.4 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $2.74 Million - $3.16 Million	16,403 Added 8.99%	198,867 $34.6 Million
Q2 2023 Aug 11, 2023	BUY	$160.94 - $186.23 $3.36 Million - $3.89 Million	20,904 Added 12.94%	182,464 $31.4 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $490,267 - $589,817	-3,370 Reduced 2.04%	161,560 $26.9 Million
Q4 2022 Feb 09, 2023	BUY	$131.14 - $157.47 $1.08 Million - $1.3 Million	8,248 Added 5.26%	164,930 $24.2 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $2.16 Million - $2.66 Million	-14,573 Reduced 8.51%	156,682 $23.3 Million
Q1 2022 May 13, 2022	BUY	$181.39 - $234.03 $114,457 - $147,672	631 Added 0.37%	171,255 $32.3 Million
Q3 2021 Oct 18, 2022	SELL	$189.29 - $209.69 $176,607 - $195,640	-933 Reduced 0.54%	170,624 $33.1 Million
Q3 2021 Nov 02, 2021	SELL	$189.29 - $209.69 $176,607 - $195,640	-933 Reduced 0.54%	170,624 $33.1 Million
Q2 2021 Oct 18, 2022	BUY	$155.9 - $187.99 $47,081 - $56,772	302 Added 0.18%	171,557 $32 Million
Q2 2021 Jul 14, 2021	SELL	$155.9 - $187.99 $1.39 Million - $1.68 Million	-8,921 Reduced 4.94%	171,557 $32 Million
Q1 2021 Oct 17, 2022	BUY	$144.0 - $169.39 $1.33 Million - $1.56 Million	9,223 Added 5.39%	180,478 $28.4 Million
Q1 2021 Apr 13, 2021	BUY	$144.0 - $169.39 $889,344 - $1.05 Million	6,176 Added 3.54%	180,478 $28.4 Million
Q4 2020 Jan 29, 2021	SELL	$157.07 - $174.35 $1.67 Million - $1.86 Million	-10,659 Reduced 5.76%	174,302 $28.8 Million
Q2 2020 Jul 31, 2020	SELL	$111.92 - $142.53 $693,344 - $882,973	-6,195 Reduced 3.24%	184,961 $24.4 Million
Q1 2020 May 01, 2020	SELL	$92.66 - $144.94 $1.28 Million - $2 Million	-13,819 Reduced 6.74%	191,156 $22.3 Million
Q4 2019 Feb 05, 2020	BUY	$116.25 - $133.25 $1.87 Million - $2.14 Million	16,079 Added 8.51%	204,975 $27.1 Million
Q3 2019 Nov 12, 2019	SELL	$112.57 - $128.43 $403,563 - $460,421	-3,585 Reduced 1.86%	188,896 $23.5 Million
Q2 2019 Jul 31, 2019	SELL	$97.98 - $114.28 $222,610 - $259,644	-2,272 Reduced 1.17%	192,481 $21.8 Million
Q1 2019 Apr 30, 2019	SELL	$81.56 - $100.67 $833,624 - $1.03 Million	-10,221 Reduced 4.99%	194,753 $0
Q4 2018 Jan 29, 2019	BUY	$79.28 - $95.27 $863,993 - $1.04 Million	10,898 Added 5.62%	204,974 $17.3 Million
Q3 2018 Nov 08, 2018	SELL	$83.5 - $93.23 $860,718 - $961,014	-10,308 Reduced 5.04%	194,076 $0
Q2 2018 Sep 19, 2018	BUY	$79.9 - $89.2 $16.3 Million - $18.2 Million	204,384 New	204,384 $17.4 Million

Others Institutions Holding ZTS

# of Institutions

2,130

Shares Held

430M

Call Options Held

1.47M

Put Options Held

1.45M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $68.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Zoetis Inc. Transaction History